# Stand-alone Left Atrial Appendage Occlusion for Thromboembolism Prevention

> **NCT05144958** · — · UNKNOWN · sponsor: **Nicolaus Copernicus University** · enrollment: 400 (estimated)

## Conditions studied

- Atrial Fibrillation
- Stroke

## Interventions

- **DEVICE:** Totally thoracoscopic LAAO - ATRICLIP
- **DEVICE:** Percutaneous LAAO - WATCHMAN
- **DEVICE:** Hybrid- minimally invasive LAAO - LARIAT

## Key facts

- **NCT ID:** NCT05144958
- **Lead sponsor:** Nicolaus Copernicus University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144958, "Stand-alone Left Atrial Appendage Occlusion for Thromboembolism Prevention". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05144958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*